University of Health Sciences Turkey İstanbul Beyoğlu Ophthalmology Training and Research Hospital, İstanbul, Turkey.
Turk J Ophthalmol. 2020 Dec 29;50(6):324-331. doi: 10.4274/tjo.galenos.2020.35305.
To evaluate the prognostic factors affecting graft survival in patients undergoing penetrating keratoplasty (PKP) for infectious keratitis.
Patients who underwent PKP for keratitis in our hospital between 2013 and 2018 were retrospectively reviewed. Patients who underwent therapeutic PKP at the inflammatory stage and were followed for at least 12 months were included in the study. Age, gender, follow-up period, time between diagnosis and surgery, lens status, presence of limbal involvement, presence of corneal ulceration, perforation, or corneal abscess, type of microorganism detected in culture, number of fortified medications used before surgery and duration of use, preoperative and postoperative visual acuity, postoperative graft transparency, postoperative complications, recurrence of infection, rate of re-keratoplasty, and indication for and timing of re-keratoplasty were recorded. The relationship between these findings and anatomic, therapeutic, and functional success were evaluated.
Fifty-nine patients were included in the study; 40 (67.8%) were male and 19 (32.2%) were female, and the mean age was 59.78±19.46 (6-91) years. Anatomic success was achieved in 58 patients (98.3%). Therapeutic success was achieved in 47 patients (79.7%) and there was a significant relationship between therapeutic success and re-keratoplasty and early re-keratoplasty (p<0.001 for both). Thirty-two patients (54.2%) had functional success and there was a significant relationship between the absence of postoperative complications and functional success (p=0.014).
PKP is an effective treatment option in treatment-resistant keratitis or keratitis with impending perforation. The absence of postoperative complications and performing early re-keratoplasty in patients with recurrence increase the success rate.
评估影响穿透性角膜移植术(PKP)治疗感染性角膜炎患者移植物存活率的预后因素。
回顾性分析 2013 年至 2018 年期间我院因角膜炎行 PKP 的患者。纳入研究的患者为在炎症期行治疗性 PKP 且随访时间至少 12 个月的患者。记录患者的年龄、性别、随访时间、从诊断到手术的时间、晶状体状态、是否存在角膜缘受累、是否存在角膜溃疡、穿孔或脓肿、培养中检测到的微生物类型、术前使用的强化药物数量和使用时间、术前和术后视力、术后移植物透明度、术后并发症、感染复发、再次行角膜移植的发生率、再次行角膜移植的适应证和时机。评估这些发现与解剖学、治疗和功能成功之间的关系。
本研究共纳入 59 例患者;其中男性 40 例(67.8%),女性 19 例(32.2%),平均年龄 59.78±19.46(6-91)岁。58 例(98.3%)患者获得解剖学成功。47 例(79.7%)患者获得治疗成功,且治疗成功与再次行角膜移植术和早期再次行角膜移植术显著相关(均 p<0.001)。32 例(54.2%)患者获得功能成功,术后无并发症与功能成功显著相关(p=0.014)。
PKP 是治疗抵抗性角膜炎或即将穿孔的角膜炎的有效治疗选择。术后无并发症且对复发患者行早期再次行角膜移植术可提高成功率。